The current study was aimed to investigate the beneficial effect of
sumatriptan, a
5-hydroxytryptamine 1B/1D (5HT1B/1D ) receptor agonist, on
gastric ulcer in rats via stimulating 5HT1B/1D receptors and suppressing pro-inflammatory
cytokines. Rats were allocated into three models of
gastric ulcer:
indomethacin (30 mg/kg, PO), water immersion restraint stress (WRS) and
ethanol (5 ml/kg PO). Animals were administered with
sumatriptan (0.01, 0.1, 0.3 and 1 mg/kg, i.p) 30 min before
gastric ulcer induction.
GR-127935 (0.01 mg/kg, i.p, a selective 5HT1B/1D antagonist) was administered 30 min before
sumatriptan (0.1 mg/kg) injection. Macroscopic assessments (J-score), ELISA analysis of tumour
necrosis factor-alpha (TNF-α) and
interleukin-1beta (IL-1β) and histopathological changes were performed on the rat's stomach tissues.
Gastric ulcer induction in three models caused an increase in J-score, TNF-α, IL-1β and microscopic features.
Sumatriptan (0.1 mg/kg) significantly improved gastric injury induced by
indomethacin, WRS and
ethanol through the reduction in the J-score, TNF-α, IL-1β and microscopic lesions. Concurrent administration of
GR-127935 (0.01 mg/kg) with
sumatriptan (0.1 mg/kg) reversed the gastroprotective effect of
sumatriptan in three models.
Sumatriptan possessed gastroprotective effects on
indomethacin-, WRS- and
ethanol-induced gastric damage in rats via the possible involvement of the 5HT1B/1D receptors.